Edition:
United Kingdom

Quest Diagnostics Inc (DGX.N)

DGX.N on New York Stock Exchange

99.28USD
19 Jul 2019
Change (% chg)

$-1.59 (-1.58%)
Prev Close
$100.87
Open
$100.77
Day's High
$100.97
Day's Low
$99.23
Volume
228,605
Avg. Vol
254,532
52-wk High
$115.64
52-wk Low
$78.97

Latest Key Developments (Source: Significant Developments)

Quest Diagnostics Inc Files For Potential Debt Shelf Offering, Size Undisclosed
Friday, 14 Jun 2019 

June 14 (Reuters) - Quest Diagnostics Inc ::QUEST DIAGNOSTICS INC FILES FOR POTENTIAL DEBT SHELF OFFERING, SIZE NOT DISCLOSED - SEC FILING.  Full Article

Quest Diagnostics Says American Medical Collection Agency Notified Co, Optum360 Of Potential Unauthorized Activity On Amca's Web Payment Page
Monday, 3 Jun 2019 

June 3 (Reuters) - Quest Diagnostics Inc ::QUEST DIAGNOSTICS - ON MAY 14, AMERICAN MEDICAL COLLECTION AGENCY NOTIFIED CO, OPTUM360 OF POTENTIAL UNAUTHORIZED ACTIVITY ON AMCA'S WEB PAYMENT PAGE..QUEST DIAGNOSTICS - AMCA INFORMED BETWEEN AUG 1, 2018 AND MARCH 30 UNAUTHORIZED USER HAD ACCESS TO AMCA'S SYSTEM.QUEST DIAGNOSTICS - AS OF MAY 31, AMCA BELIEVES NUMBER OF CO'S PATIENTS WHOSE INFORMATION CONTAINED ON AMCA'S AFFECTED SYSTEM WAS ABOUT 11.9 MILLION PEOPLE.QUEST DIAGNOSTICS INC - SUSPENDED SENDING COLLECTION REQUESTS TO AMCA.QUEST DIAGNOSTICS INC - INSURANCE COVERAGE IN PLACE FOR CERTAIN POTENTIAL LIABILITIES AND COSTS RELATING TO INCIDENT.QUEST DIAGNOSTICS - WORKING, WITH OPTUM360, AMCA AND OUTSIDE SECURITY EXPERTS, TO INVESTIGATE AMCA DATA SECURITY INCIDENT.QUEST DIAGNOSTICS - AMCA INFORMED INFORMATION ON AMCA'S AFFECTED SYSTEM INCLUDED FINANCIAL INFORMATION, MEDICAL INFORMATION, OTHER PERSONAL INFORMATION.  Full Article

Quest Diagnostics Reports Q1 Diluted EPS of $1.20
Tuesday, 23 Apr 2019 

April 23 (Reuters) - Quest Diagnostics Inc ::QUEST DIAGNOSTICS REPORTS FIRST QUARTER 2019 FINANCIAL RESULTS.OUTLOOK FOR FULL-YEAR 2019 REMAINS UNCHANGED..Q1 EARNINGS PER SHARE $1.20.Q1 REVENUE ROSE 0.4 PERCENT TO $1.89 BILLION.Q1 REPORTED DILUTED EPS OF $1.20.QTRLY NET REVENUES $1,891 MILLION VS $1,884 MILLION.QTRLY ADJUSTED DILUTED EPS OF $1.40.Q1 EARNINGS PER SHARE VIEW $1.36, REVENUE VIEW $1.87 BILLION -- REFINITIV IBES DATA.  Full Article

Quest Diagnostics CEO's Total 2018 Compensation Was $10 Mln Versus $10.3 Mln In 2017
Wednesday, 3 Apr 2019 

April 3 (Reuters) - Quest Diagnostics Inc ::QUEST DIAGNOSTICS INC - CEO STEPHEN RUSCKOWSKI'S TOTAL 2018 COMPENSATION WAS $10 MILLION VERSUS $10.3 MILLION IN 2017.QUEST DIAGNOSTICS INC - 2018 MEDIAN EMPLOYEE TO CEO PAY RATIO WAS ESTIMATED TO BE APPROXIMATELY 1 TO 213..  Full Article

Quest Diagnostics Prices $500 Million Of Senior Notes
Thursday, 7 Mar 2019 

March 7 (Reuters) - Quest Diagnostics Inc ::QUEST DIAGNOSTICS PRICES $500 MILLION OF SENIOR NOTES.QUEST DIAGNOSTICS INC - A PUBLIC OFFERING OF $500 MILLION AGGREGATE PRINCIPAL AMOUNT OF ITS 4.200% SENIOR NOTES DUE 2029.  Full Article

Quest Diagnostics Inc Files For Offering Of Senior Notes Due 2029
Thursday, 7 Mar 2019 

March 7 (Reuters) - Quest Diagnostics Inc ::QUEST DIAGNOSTICS INC FILES FOR OFFERING OF UP TO $500 MILLION OF SENIOR NOTES DUE 2029 - SEC FILING.QUEST DIAGNOSTICS INC SAYS NOTES WILL BE ISSUED IN MINIMUM DENOMINATIONS OF $2,000 AND INTEGRAL MULTIPLES OF $1,000 IN EXCESS THEREOF.  Full Article

Quest Diagnostics-Raises Dividend By 6 Pct To An Annual Rate Of $2.12 Per Share
Wednesday, 28 Nov 2018 

Nov 28 (Reuters) - Quest Diagnostics Inc ::RAISES DIVIDEND BY 6% TO AN ANNUAL RATE OF $2.12 PER SHARE.2018 REPORTED REVENUES NOW EXPECTED TO BE APPROXIMATELY $7.57 BILLION.CASH PROVIDED BY OPERATIONS NOW EXPECTED TO APPROXIMATE $1.25 BILLION IN 2018.QUEST DIAGNOSTICS - 2018 REPORTED DILUTED EPS EXPECTED TO BE GREATER THAN $5.34, ADJUSTED DILUTED EPS EXPECTED TO BE GREATER THAN $6.30.FY2018 EARNINGS PER SHARE VIEW $6.56, REVENUE VIEW $7.62 BILLION -- REFINITIV IBES DATA.  Full Article

Quest Diagnostics to build flagship laboratory at Visionary Campus in Clifton
Wednesday, 28 Nov 2018 

Nov 28 (Reuters) - Quest Diagnostics Inc ::QUEST DIAGNOSTICS TO BUILD FLAGSHIP LABORATORY AT VISIONARY CAMPUS IN CLIFTON, NEW JERSEY TO EMPOWER BETTER HEALTH FOR PATIENTS IN SEVEN STATES.QUEST DIAGNOSTICS - NEW LABORATORY WILL EMPLOY MORE THAN 1,100 PEOPLE.QUEST DIAGNOSTICS INC - NEW LABORATORY IS EXPECTED TO BE OPERATIONAL IN EARLY 2021.  Full Article

Quest Diagnostics To buy Laboratory Services Business Of Boyce And Bynum Pathology Laboratories
Tuesday, 27 Nov 2018 

Nov 27 (Reuters) - Quest Diagnostics Inc ::QUEST DIAGNOSTICS TO ACQUIRE THE LABORATORY SERVICES BUSINESS OF BOYCE AND BYNUM PATHOLOGY LABORATORIES, EXPANDING DIAGNOSTIC INNOVATION IN THE MIDWEST.QUEST DIAGNOSTICS INC - ADDITIONAL FINANCIAL TERMS OF TRANSACTION WERE NOT DISCLOSED..  Full Article

Quest Diagnostics Reports Q3 Reported Diluted EPS Of $1.53
Tuesday, 23 Oct 2018 

Oct 23 (Reuters) - Quest Diagnostics Inc ::QUEST DIAGNOSTICS REPORTS THIRD QUARTER 2018 FINANCIAL RESULTS.THIRD QUARTER REVENUES OF $1.89 BILLION, UP 1.8% FROM 2017.UPDATES OUTLOOK FOR FULL-YEAR 2018.THIRD QUARTER REPORTED DILUTED EPS OF $1.53.SEES FY 18 REPORTED DILUTED EPS NOW EXPECTED TO BE BETWEEN $5.57 AND $5.64.THIRD QUARTER ADJUSTED DILUTED EPS EXCLUDING AMORTIZATION OF $1.68.SEES FY 2018 REPORTED REVENUES NOW EXPECTED TO BE APPROXIMATELY $7.62 BILLION.SEES FY 18 ADJUSTED DILUTED EPS EXCLUDING AMORTIZATION EXPENSE NOW EXPECTED TO BE BETWEEN $6.53 AND $6.60.  Full Article

UPDATE 1-Opko Health says over 400,000 customers likely affected by data breach

June 6 Opko Health Inc said on Thursday it was notified by its former billing collections vendor about unauthorized access to information on about 422,600 customers, making it the third healthcare company to be affected by the incident.